Yanki Yarman: Linking Genetic Variants to Clinical Outcomes in Thrombosis
Yanki Yarman, MD and Ph.D. Student at Sidney Kimmel Medical College, shared a post on LinkedIn about a recent article by Marvin T. Nieman, published in ASH, adding:
“I’m truly touched and honored by this Blood commentary penned by Dr. Marvin Nieman on my PhD project.
I’m especially grateful for his description of our study and its comprehensive methods ‘as a model for future studies aiming to connect genetic variants with molecular mechanisms and clinical outcomes.’
As a physician-scientist in training, I care deeply about genetically screening patients and understanding the molecular pathways underlying their diseases.
I hope to practice personalized medicine in the near future.
Here’s the Blood commentary on the GRK5 variant that we linked to increased thrombotic risk.”
Title: GRK5 polymorphism turns up the volume on PAR1
Auhtors: Marvin Nieman
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology
-
Sep 23, 2026, 13:04Ben Samelson-Jones: Do Gene Variants Drive PK Differences in FIX-Fusion and N9-GP Therapies?
-
Sep 23, 2026, 12:57Shelly Reed: Advocating for HTCs and CDC Funding with the Hemophilia Federation of America
-
Sep 23, 2026, 12:51Domenico Girelli: How Verona Hospital Transformed ED Anemia Care with Patient Blood Management
-
Sep 23, 2026, 12:45Lina Camacho-Arteaga: ENTIS Study Uncovers Safety Data on Early Pregnancy Exposure to Direct Oral Anticoagulants
-
Sep 23, 2026, 12:34Hiteshi K.C. Chauhan: Why Mechanical Valve Thrombosis Is a Systems Failure, Not Just an Anticoagulation Error
-
Sep 23, 2026, 12:33World Thrombosis Day 2026 Puts Women’s Health in Focus – JTH
-
Sep 23, 2026, 12:30Zain Khalpey: How a Sudden Blockage Causes Myocardial Infarction